An Act Requiring Health Insurance Coverage For Fertility Preservation For Insureds Diagnosed With Cancer.
Impact
The introduction of HB 05230 represents a significant shift in health insurance regulations, potentially broadening the spectrum of medical necessities considered for coverage within state laws. It is expected to alleviate financial burdens for cancer patients seeking to preserve their fertility, ensuring that necessary procedures related to fertility and reproductive health are accessible. However, the bill also includes stipulations that can limit the extent of this coverage based on the individual's age and the number of procedures performed, which might limit some patients' options.
Summary
House Bill 05230 seeks to mandate health insurance coverage for fertility preservation procedures for insured individuals diagnosed with cancer who have not yet commenced treatment. This includes coverage for embryo, oocyte, and sperm cryopreservation procedures for patients aged eighteen and older. The legislation aims to provide essential medical support for cancer patients wishing to preserve their reproductive capabilities before undergoing potentially sterilizing treatments such as chemotherapy or radiation. Importantly, the bill outlines that the required coverage must align with guidelines established by the American Society of Clinical Oncology.
Sentiment
The sentiment surrounding HB 05230 appears to be largely positive, particularly among those directly affected by cancer diagnoses. Supporters express appreciation for the increased access to fertility preservation methods, viewing it as an important step towards comprehensive reproductive health care. Critics, however, may raise concerns regarding the exclusions allowed for religious or moral objections from certain insurers, which could complicate access for some patients based on their beliefs.
Contention
Contention primarily revolves around the limitations imposed by the bill regarding the age of eligibility and the lifetime caps on the number of procedures covered. These provisions have been flagged by some stakeholders as potentially restrictive, particularly for women who may wish to preserve their fertility beyond the age limit set by the legislation. Additionally, the allowance for policies to exclude coverage based on religious beliefs may lead to disparities in care and access to fertility preservation procedures across different insurer offerings.
An Act Prohibiting Certain Health Carriers From Requiring Step Therapy For Prescription Drugs Used To Treat A Mental Or Behavioral Health Condition Or A Chronic, Disabling Or Life-threatening Condition.
An Act Concerning Insurance Market Conduct And Insurance Licensing, The Insurance Department's Technical Corrections And Other Revisions To The Insurance Statutes And Captive Insurance.
Requesting The Auditor To Assess The Social And Financial Effects Of Mandatory Health Insurance Coverage For Fertility Preservation Procedures For Certain Persons Who Have Been Diagnosed With Cancer And Whose Cancer Or Cancer Treatment May Adversely Affect Their Fertility.
Requesting The Auditor To Assess The Social And Financial Effects Of Mandatory Health Insurance Coverage For Fertility Preservation Procedures For Certain Persons Who Have Been Diagnosed With Cancer And Whose Cancer Or Cancer Treatment May Adversely Affect Their Fertility.